Overview Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3) Status: Completed Trial end date: 2008-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether bivalirudin given during PCI is associated with better outcomes compared to un-fractionated heparin. Phase: Phase 4 Details Lead Sponsor: Deutsches Herzzentrum MuenchenTreatments: BivalirudinCalcium heparinHeparinHirudins